Liver is the most common site for distant metastasis in ovarian cancer, with a median overall survival of 11 months for affected patients. A new nomogram was developed using SEER data, identifying age ...

Sofetabart mipitecan (LY4170156), an investigational folate receptor alpha (FRα)-targeted antibody-drug conjugate (ADC), elicited strong antitumor activity in patients with recurrent ...

For patients with ovarian cancer who are in remission, the probability of remaining disease-free improves considerably over time, and conditional disease-free survival might be a good estimate of ...

MUC16 is highly and stably expressed in the most aggressive and most common subtypes of endometrial cancer Findings support Whitehawk's development of MUC16-directed ADC, HWK-016, currently being ...

Ovarian cancer is the most lethal malignancy of the female reproductive system. Due to its insidious early symptoms and the ...

Stage 2 ovarian cancer is localized to the pelvis, with substages 2A and 2B indicating specific spread patterns. Diagnosis involves physical exams, imaging, blood tests, and biopsy to confirm cancer ...